Search clinical trials for: oral anticoagulant

Total 23173 results

Bayer

Completed

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Venous Thrombosis | Deep Vein Thrombosis

Belgium, Israel, Italy, Spain, Switzerland, Colombia, New Zealand, Hungary, Canada, Sweden, Austria, Czechia, Germany, Poland, Netherlands, Peru, South Africa, Australia, Brazil
Takeda

Completed

A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

Helicobacter Pylori

China
Daniel Benjamin
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (PTN_POPS)

Heart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditions

United States, Canada, United Kingdom, Israel, Singapore
The University of Texas Medical Branch, Galveston

Completed

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia (IVIRONMAN)

Anemia, Iron Deficiency | Delivery Complication

United States
University Hospital, Strasbourg, France

Active, not recruiting

Oral Anticoagulation in Haemodialysis Patients (AVKDIAL)

Kidney Failure, Chronic

France
TAHO Pharmaceuticals Ltd.

Completed

Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers (TAH-12288201)

Healthy Volunteers | Fasting | Fed

United States
Mt. Sinai Medical Center, Miami
National Heart, Lung, and Blood Institute (NHLBI); National Center for Complementary... and other collaborators

Completed

Trial to Assess Chelation Therapy 2 (TACT2)

Myocardial Infarction | Diabetes

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
University Hospital, Basel, Switzerland

Completed

New Oral Anticoagulants (NOAC) in Stroke Patients (NOACISPLongTer)

Stroke | Atrial Fibrillation

Switzerland
Portola Pharmaceuticals

Completed

Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin (EXPLORE-Xa)

Atrial Fibrillation

United States, Canada
Portola Pharmaceuticals

Completed

An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects

Health Volunteers
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF (APERITIF)

Myocardial Infarction, Acute | Left Ventricular Thrombus

France
Atrial Fibrillation Network
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Deutsches Zentrum für...

Terminated

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes (NOAH)

Atrial High Rate Episodes

Austria, Belgium, Bulgaria, Czechia, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, Ukraine, United Kingdom, Denmark
Ajou University School of Medicine

Active, not recruiting

Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation (Paradox)

Obesity | Atrial Fibrillation | Prognosis | Anticoagulants

Korea, Republic of
American University of Beirut Medical Center

Active, not recruiting

Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro Fertilization

Infertility | PCO - Polycystic Ovaries

Lebanon
Arianna Anticoagulazione Foundation

Completed

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS) (MAS)

Atrial Fibrillation | Anticoagulant-induced Bleeding

Italy
Insel Gruppe AG, University Hospital Bern

Completed

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial (ELAN)

Ischaemic Stroke

Belgium, Ireland, Israel, Germany, India, United Kingdom, Austria, Switzerland, Finland, Norway, Italy, Portugal, Slovakia, Japan, Greece
Mostafa Hassanein, Msc

Completed

The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

Sport Injury | Muscle Injury | PRP | Losartan
Memorial Sloan Kettering Cancer Center

Completed

Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Multiple Myeloma

United States
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Daiichi Sankyo, Inc.

Completed

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

Atrial Fibrillation

Turkey
University Hospital Heidelberg
Bristol-Myers Squibb; Boehringer Ingelheim; Daiichi Sankyo, Inc.; University of... and other collaborators

Completed

Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime (RASUNOA-Prime)

Cardiovascular Diseases | Vascular Diseases | Ischemic Stroke | Intracerebral Hemorrhage | Oral Anticoagulation

Germany
Unity Health Toronto
Canadian Institutes of Health Research (CIHR); The George Institute for Global...

Completed

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis (SAFE-D)

Atrial Fibrillation | End Stage Renal Failure on Dialysis

Canada, Australia
Bristol-Myers Squibb

Completed

A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) (EQUAL-AF)

Atrial Fibrillation

United Kingdom
Fundación de Investigación Biomédica - Hospital...

Active, not recruiting

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

Atrial Fibrillation

Spain
VarmX B.V.

Completed

Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects

Coagulation Disorder

Netherlands
Mayo Clinic
Satiogen Pharmaceuticals, Inc.

Completed

Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

Overweight | Type 2 Diabetes Mellitus | Obese

United States
Beni-Suef University

Completed

Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness

Infertility, Female

Egypt
Regeneron Pharmaceuticals

Completed

Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

Healthy Volunteer

United Kingdom
Pfizer

Completed

Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

Obesity | Atrial Fibrillation | Anticoagulants

United States
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
William Beaumont Hospitals
Johns Hopkins University; University of Pennsylvania; London Health Sciences...

Withdrawn

Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

Atrial Fibrillation

United States
Science Valley Research Institute
Bayer

Completed

Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients

Intermittent Claudication | Peripheral Artery Disease

Brazil
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Completed

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry (PAUSE-ER)

Atrial Fibrillation | Venous Thromboembolism | Arterial Vascular Disease

Canada
Region Örebro County

Completed

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

Atrial Fibrillation | Stroke, Ischemic

Sweden
Prince of Wales Hospital, Shatin, Hong Kong

Enrolling by invitation

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet (COMPAWA)

Combined Pulsed-field Ablation (PFA)

Hong Kong
Groupe Maladies hémorragiques de Bretagne

Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia (KADOAH)

Hemophilia A | Hemophilia B | Anticoagulant-induced Bleeding

France
Assistance Publique Hopitaux De Marseille

Completed

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Atrial Fibrillation
Alexion

Terminated

Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery (Annexa-S)

Surgery

United States, Germany, Israel, France, Austria, Japan
Laval University

Withdrawn

DOAC Versus VKA After Cardiac Surgery (DOAC/VKA)

Anticoagulant-induced Bleeding

Canada
Portola Pharmaceuticals

Completed

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

Hepatic Impairment

United States
Damascus University
Unipharma, HamaPharma, Almujtahed hospital

Completed

Rivaroxaban vs. Warfarin in CVT Treatment (RWCVT)

Cerebral Vein Thrombosis

Syrian Arab Republic
Tufts Medical Center

Terminated

Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

Constipation

United States
NICHD Neonatal Research Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial (MoCHA)

Apnea of Prematurity

United States
Cardioangiologisches Centrum Bethanien

Completed

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Venous Thromboembolism | Antiphospholipid Syndrome | Major Bleed | Arterial Thromboembolism

Germany
University Hospital, Caen
University Hospital, Rouen

Completed

Apixaban in Subjects With Peritoneal Dialysis (ApiDP)

Peritoneal Dialysis | Chronic Renal Insufficiency

France
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

Chronic Hepatitis B

China
University Hospital, Basel, Switzerland
Swiss Heart Foundation

Completed

Novel Oral Anticoagulants in Stroke Patients (NOACISP)

Ischemic Stroke | Intracranial Hemorrhages

Switzerland
Zealand University Hospital
Hvidovre University Hospital

Active, not recruiting

Patient Reported Outcome After Stemmed Versus Stemless Total Shoulder Arthroplasty for Glenohumeral Osteoarthritis.

Shoulder Pain | Shoulder Osteoarthritis | Shoulder Arthritis

Denmark
University Hospital, Basel, Switzerland
University of Basel; Clinical Trial Unit, University Hospital Basel, Switzerland

Completed

Electronic Monitoring and Improvement of Adherence to DOACs in Polymedicated Stroke Patients (MAAESTRO)

Stroke, Ischemic | Adherence, Patient

Switzerland
Altimmune, Inc.

Completed

ALT-801 DDI Study in Healthy Volunteers

NASH - Nonalcoholic Steatohepatitis

Australia

Search clinical trials for: oral anticoagulant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations